Ferrara, N., et al., "The Vascular Endothelial Growth Factor Family of Polypeptides," Journal of Cellular Biochemistry, 47:211-218 (1991). |
Tischer, E., et al., "The Human Gene for Vascular Endothelial Growth Factor," The Journal of Biological Chemistry, 266(18):11947-11954 (1991). |
Tischer, E., et al., "Vascular Endothelial Growth Factor: A New Member of the Platelet-Derived Growth Factor Gene Family," Biochemical and Biophysical Research Communications, 165(3):1198-1206 (1989). |
Chamow, S.M., et al. "Immunoadhesins: principles and applications", Tibtech, vol. 14, pp. 52-60 (1996). |
Cunningham, S.A., "Identification of the Extracellular Domains of Flt-1 That Mediate Ligand Interactions", Biochemical and Biophysical Research Communications, 231: pp. 596-599 (1997). |
Davis-Smyth, T., et al. "The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade", The EMBO Journal, vol. 15, No. 18, pp. 4919-4927 (1996). |
Creighton, Proteins, WH Freeman and Company: New York, NY, pp. 223-227, 1984. |
Schulz et al., Principles of Protein Structure, Springer-Verlag: New York, NY, pp. 14-16, 1979. |
Ailello et al., Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins, Proc. Natl. Acad. Sci. USA, 92(23): 10457-10461, Nov. 1995. |
Park et al., Placenta growth factor, J. Biol. Chem., 269(41): 25646-25654, Oct. 1994. |
Plowman et al., Receptor tyrosine kinases as targets for drug intervention, DN&P, 7(6): 334-339, Aug. 1994. |
Heidaran et al., Beta PDGFR-IgG chimera demonstrates that human beta PDGFR Ig-like domains 1 to 3 are sufficient for high affinity PDGF BB binding, FASEB J., 9: 140-145, 1995. |
Cheon et al., High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains, Proc. Natl. Acad. Sci. USA, 91: 989-993, Feb. 1994. |
Klein, Immunogy: The Science of Self-Nonself Discrimination, Wiley-Interscience: New York, NY, pp. 160-161 and 190-191, 1982. |
Rockwell et al., In vitro neutralization of vascular endothelial growth factor activation of flk-1 by monoclonal antibody, Mol. Cell. Differ., 3(1): 91-109, 1995. |
Kendall et al., Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor, Proc. Natl. Acad. Sci. USA, 90: 10705-10709, Nov. 1993. |